Banasco, Janebeth ..

HRN: 21-23-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2022
CEFUROXIME 1.5GM (VIAL)
04/12/2022
04/18/2022
IV
1.5 THEN 750MG
LD THEN Q8
PUS CELLS 16-20
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Dose  1.5g All Throughout The Tx Course (NAG)

Final appropriateness: No  Wrong Dose 

Overall appropriateness: No 

Intervention



Type of Intervention done:

                    

           


Acceptance: